Table 2 Treatment outcomes of DR-TB patients in the Rabat-Salé-Kénitra region by resistance pattern, from to 2014 to 2016
Treatment outcomes, n (%) | MDR | Rifampicin resistance | Isoniazid resistance | Total |
|---|---|---|---|---|
Cured | 34 (33.7) | 10 (9.9) | 1 (1) | 45 (44.5) |
Completed | 7 (6.9) | 2 (2) | 0 (0) | 9 (8.9) |
Lost to follow up | 23 (22.8) | 11 (10.9) | 1 (1) | 35 (34.6) |
Failed | 7 (6.9) | 0 (0) | 0 (0) | 7 (6.9) |
Died | 3 (3) | 2 (2) | 0 (0) | 5 (4.9) |
Successful treatment (cured + completed) | 41 (40.6) | 12 (11.9) | 1 (1) | 54 (53.5) |
Poor treatment (failure + death + lost to follow up) | 33 (32.7) | 13 (12.9) | 1 (1) | 47 (46.5) |